CYCLOPLEGIC RETINOSCOPY.pdf

•

0 likes•6 views

Al-Shifa College of Paramedical Science,Perinthalmanna

CYCLOPLEGIC RETINOSCOPY

Health & Medicine

$What is wet retinoscopy and dry retinoscopy?  'Dry' retinoscopy refers to various techniques that can be performed to determine the refractive state of the eye without the use of pharmacological agents. When such agents are used the technique is referred to as 'wet' retinoscopy.$

More from Al-Shifa College of Paramedical Science,Perinthalmanna

ANATOMY OF SCLERA.pdf

Al-Shifa College of Paramedical Science,Perinthalmanna

ANATOMY OF UVEA.pdf

Al-Shifa College of Paramedical Science,Perinthalmanna

07 INDICATIONS & CONTRA INDICATIONS OF CL.pptx

Al-Shifa College of Paramedical Science,Perinthalmanna

3 physiology (Ant.segment) .ppt

Al-Shifa College of Paramedical Science,Perinthalmanna

2 anatomy(Ant.segment-2) .pptx

Al-Shifa College of Paramedical Science,Perinthalmanna

1 Anatomy(Ant.segment-1) .pptx

Al-Shifa College of Paramedical Science,Perinthalmanna

Quality Assurance and Inspection OF CL.pptx

Al-Shifa College of Paramedical Science,Perinthalmanna

01 & 02 Introduction & history of Contact Lenses.pptx

Al-Shifa College of Paramedical Science,Perinthalmanna

03 Optics of CL .ppt

Al-Shifa College of Paramedical Science,Perinthalmanna

05 & 06 Introduction to CL materials.pptx

Al-Shifa College of Paramedical Science,Perinthalmanna

08 CONTACT LENS PARAMETERS .pptx

Al-Shifa College of Paramedical Science,Perinthalmanna

09 Contact Lens MATERIALS .pptx

Al-Shifa College of Paramedical Science,Perinthalmanna

Aberrometry .pdf

Al-Shifa College of Paramedical Science,Perinthalmanna

Keratometer .pdf

Al-Shifa College of Paramedical Science,Perinthalmanna

PLACIDO DISC .pdf

Al-Shifa College of Paramedical Science,Perinthalmanna

CONTACT LENS PARAMETERS.pptx

Al-Shifa College of Paramedical Science,Perinthalmanna

SPECTACLE FRAMES & PARTS.pptx

Al-Shifa College of Paramedical Science,Perinthalmanna

MYOPIA REFRACTIVE ERROR.pdf

Al-Shifa College of Paramedical Science,Perinthalmanna

ANISOMETROPIA & PSEUDOPHAKIA.pdf

Al-Shifa College of Paramedical Science,Perinthalmanna

ANATOMY & PHYSIOLOGY OF TEAR FILM FOR CONTACT LENS FITTING.pdf

Al-Shifa College of Paramedical Science,Perinthalmanna

More from Al-Shifa College of Paramedical Science,Perinthalmanna (20)

ANATOMY OF SCLERA.pdf

ANATOMY OF UVEA.pdf

07 INDICATIONS & CONTRA INDICATIONS OF CL.pptx

3 physiology (Ant.segment) .ppt

2 anatomy(Ant.segment-2) .pptx

1 Anatomy(Ant.segment-1) .pptx

Quality Assurance and Inspection OF CL.pptx

01 & 02 Introduction & history of Contact Lenses.pptx

03 Optics of CL .ppt

05 & 06 Introduction to CL materials.pptx

08 CONTACT LENS PARAMETERS .pptx

09 Contact Lens MATERIALS .pptx

Aberrometry .pdf

Keratometer .pdf

PLACIDO DISC .pdf

CONTACT LENS PARAMETERS.pptx

SPECTACLE FRAMES & PARTS.pptx

MYOPIA REFRACTIVE ERROR.pdf

ANISOMETROPIA & PSEUDOPHAKIA.pdf

ANATOMY & PHYSIOLOGY OF TEAR FILM FOR CONTACT LENS FITTING.pdf

Recently uploaded

PT MANAGEMENT OF URINARY INCONTINENCE.pptx

drtabassum4

Compare home pulse pressure components collected directly from home

Catherine Liao

The hemodynamic and autonomic determinants of elevated blood pressure in obes...

Catherine Liao

Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.

Report Back from SGO 2024: What’s the Latest in Cervical Cancer?

bkling

Temporal, Infratemporal & Pterygopalatine BY Dr.RIG.pptx

Dr. Rabia Inam Gandapore

CURRENT HEALTH PROBLEMS AND ITS SOLUTION BY AYURVEDA.pptx

Dr KHALID B.M

Linearity concept of significance, standard deviation, chi square test, students T- test, ANOVA test , pharmaceutical science, statistical analysis, statistical methods, optimization technique, modern pharmaceutics, pharmaceutics, mpharm 1 unit i sem, 1 year m pharm, applications of chi square test, application of standard deviation , pharmacy, method to compare dissolution profile, statistical analysis of dissolution profile, important statical analysis, m. pharmacy, graphical representation of standard deviation, graph of chi square test, graph of T test , graph of ANOVA test ,formulation of t test, formulation of chi square test, formula of standard deviation.

linearity concept of significance, standard deviation, chi square test, stude...

KavyasriPuttamreddy

i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource. This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and Associate Division Director for Ambulatory Operations The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma. STATEMENT OF NEED Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL. Target Audience Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL). Learning Objectives 1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL 2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults 3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection

New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...

i3 Health

DECIPHERING COMMON ECG FINDINGS IN ED.pptx

drwaque

The POPPY STUDY (Preconception to post-partum cardiovascular function in prim...

Catherine Liao

Young at heart: Cardiovascular health stations to empower healthy lifestyle b...

Catherine Liao

RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0). CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...

Oleg Kshivets

TEST BANK For Williams' Essentials of Nutrition and Diet Therapy, 13th Editio...

kevinkariuki227

TEST BANK For Timby's Introductory Medical-Surgical Nursing, 13th American Ed...

kevinkariuki227

"Central Hypertension"‚ in China: Towards the nation-wide use of SphygmoCor t...

Catherine Liao

Contact us if you are interested: Email / Skype : kefaya1771@gmail.com Threema: PXHY5PDH New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH ! Contact me on Threema or skype to start big business!! Hot-sale products: NEW HOT EUTYLONE WHITE CRYSTAL!! 5cl-adba precursor (semi finished ) 5cl-adba raw materials ADBB precursor (semi finished ) ADBB raw materials APVP powder 5fadb/4f-adb Jwh018 / Jwh210 Eutylone crystal Protonitazene (hydrochloride) CAS: 119276-01-6 Flubrotizolam CAS: 57801-95-3 Metonitazene CAS: 14680-51-4 Payment terms: Western Union,MoneyGram,Bitcoin or USDT. Deliver Time: Usually 7-15days Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet. Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details. We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.

HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...

GL Anaacs

Relationship between vascular system disfunction, neurofluid flow and Alzheim...

Catherine Liao

Effects of vaping e-cigarettes on arterial health

Catherine Liao

Impact of cancers therapies on the loss in cardiac function, myocardial fffic...

Catherine Liao

For Better Surat #ℂall #Girl Service ❤85270-49040❤ Surat #ℂall #Girls

Savita Shen $i11

Recently uploaded (20)